Literature DB >> 3036712

Etiological, clinical and laboratory data of post-transfusion hepatitis: a retrospective study of 379 cases from 53 Italian hospitals.

G Giusti, B Galanti, G B Gaeta, C Gallo.   

Abstract

Among the 8,604 cases of acute viral hepatitis hospitalized during 1982 in 53 Italian hospitals, we studied 379 cases of post-transfusion hepatitis, 262 cases which occurred after surgery and 4,576 cases with no history of parenteral exposure. The etiological agents of post-transfusion hepatitis were NANB viruses in 57.8%, HBV in 39.0% and HAV in 3.2% of the cases. CMV and EBV accounted for less than 1.5% of the post-transfusion hepatitis cases. HBV was the main etiological agent (62.2% of the cases) in the post-surgical hepatitis group, where HAV accounted for only 6.1% of the cases. In contrast, in the group with no history of parenteral exposure, hepatitis A was most frequent. Percentages of patients with history of transfusion or surgery were always higher in type B and NANB hepatitis than in type A, suggesting that surgery without transfusion also represents a risk of acquiring type B and NANB hepatitis. No regional differences were observed in the etiological patterns of post-transfusion hepatitis and post-surgical hepatitis. The acute phase of type B post-transfusion hepatitis was more severe than that of NANB post-transfusion hepatitis, as shown by higher serum bilirubin and ALT levels and by a higher case fatality rate.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3036712     DOI: 10.1007/BF01650209

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  14 in total

1.  Non-A, non-B hepatitis in Milan.

Authors:  F Caredda; A d'Arminio Monforte; E Rossi; S Lopez; M Moroni
Journal:  Lancet       Date:  1981-07-04       Impact factor: 79.321

2.  Post-transfusion hepatitis in Australia. Report of the Australian Red Cross study.

Authors:  Y E Cossart; S Kirsch; S L Ismay
Journal:  Lancet       Date:  1982-01-23       Impact factor: 79.321

3.  Prospective study of posttransfusion hepatitis in cardiac surgery patients receiving only blood or also blood products.

Authors:  F Tremolada; F Chiappetta; F Noventa; C Valfrè; G Ongaro; G Realdi
Journal:  Vox Sang       Date:  1983       Impact factor: 2.144

Review 4.  [Post-transfusion hepatitis: the point of view of the infectious disease specialist].

Authors:  G Giusti; B Galanti
Journal:  Ric Clin Lab       Date:  1984

Review 5.  [Currently available means for the prevention of post-transfusion hepatitis and criteria for their application].

Authors:  G Bedarida; G Cambiè; F D'Agostino; G Sterza
Journal:  Ric Clin Lab       Date:  1984

Review 6.  A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. A Veterans Administration cooperative study.

Authors:  L B Seeff; H J Zimmerman; E C Wright; J D Finkelstein; P Garcia-Pont; H B Greenlee; A A Dietz; C M Leevy; C H Tamburro; E R Schiff; E M Schimmel; R Zemel; D S Zimmon; R W McCollum
Journal:  Gastroenterology       Date:  1977-01       Impact factor: 22.682

7.  Donor transaminase and recipient hepatitis. Impact on blood transfusion services.

Authors:  H J Alter; R H Purcell; P V Holland; D W Alling; D E Koziol
Journal:  JAMA       Date:  1981-08-07       Impact factor: 56.272

8.  HBsAg carriers among blood donors in Italy; a retrospective survey of data from 189 blood banks.

Authors:  G Giusti; B Galanti; G B Gaeta; F Piccinino; G Ruggiero
Journal:  Hepatogastroenterology       Date:  1981-04

9.  Posttransfusion hepatitis type A.

Authors:  F B Hollinger; N C Khan; P E Oefinger; D H Yawn; A C Schmulen; G R Dreesman; J L Melnick
Journal:  JAMA       Date:  1983-11-04       Impact factor: 56.272

10.  Posttransfusion hepatitis in Spain. A prospective study.

Authors:  J M Hernández; J Piqueras; A Carrera; J Triginer
Journal:  Vox Sang       Date:  1983       Impact factor: 2.144

View more
  1 in total

1.  PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN HOSPITALIZED POPULATION SUBSETS.

Authors:  V C Ohri; Mkk Rao; K Banerjee; D Raghunath; K Kher; R M Gupta; S K Nema; Lavan Singh
Journal:  Med J Armed Forces India       Date:  2017-06-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.